RxDoctor Payments DataLook up a doctor →

Perry Foreman, MD

Neurology · Baltimore, MDNPI 1346231677

Payments from drug & device makers

$194,300in general payments, 2019–2025

Across 759 payments — averaging $255.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • SK Life Science, Inc.$81K
  • UCB, Inc.$55K
  • Eisai Inc.$18K
  • Livanova USA, Inc.$10K
  • Sunovion Pharmaceuticals Inc.$10K
  • Catalyst Pharmaceuticals, Inc.$9K
  • plus $12K from 41 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
SK Life Science, Inc.136$81,188
UCB, Inc.129$54,627
Eisai Inc.45$17,771
Livanova USA, Inc.31$9,813
Sunovion Pharmaceuticals Inc.49$9,582
Catalyst Pharmaceuticals, Inc.12$8,842
Neurelis, Inc.25$3,818
Ceribell, Inc.4$1,983
AbbVie(2 entities)104$1,711
Novartis53$785
Jazz Pharmaceuticals Inc.17$778
Biogen16$320
Teva Pharmaceuticals USA, Inc.11$279
Amgen(2 entities)8$244
Greenwich Biosciences, Inc.14$239
Neuropace, Inc.3$233
Lilly USA, LLC10$192
EMD Serono, Inc.10$184
Sanofi10$173
Acadia Pharmaceuticals Inc10$151
Takeda Pharmaceuticals U.S.A., Inc.6$131
Lundbeck LLC5$129
Sumitomo Pharma America, Inc.7$122
AstraZeneca5$122
Biocodex, Inc.1$85
Medtronic1$76
Argenx US, Inc.3$69
Merz Pharmaceuticals, LLC3$63
CSL Behring3$60
Biohaven Pharmaceutical Holding Company Ltd.3$60
TG Therapeutics, Inc.3$58
Alnylam Pharmaceuticals Inc.2$58
Tanabe Pharma America, Inc.2$45
Biohaven Pharmaceuticals, Inc.2$40
Banner Life Sciences, LLC2$34
Shire North American Group Inc2$32
Supernus Pharmaceuticals, Inc.2$27
Impel Pharmaceuticals Inc.1$25
Pfizer1$21
Aquestive Therapeutics, Inc.1$20
Avanir Pharmaceuticals, Inc.1$19
Otsuka America Pharmaceutical, Inc.1$19
Bristol Myers Squibb1$18
Mallinckrodt Enterprises LLC1$16
Currax Pharmaceuticals LLC1$15
Aucta Pharmaceuticals, Inc.1$14
Johnson & Johnson1$11

How this compares

$194,300 in reported general payments places this provider in the 90th percentile of 442 neurology providers in Maryland.

See all neurology providers in Maryland →

Medicare billing

Part B allowed, 2024
$79,825
Medicare patients
382
Services billed
901

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other neurology in Baltimore

See the full list for Maryland →

Where these figures come from

Is this you, or does something look wrong? →